Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group with varied pathophysiological, genetic, and clinical features, accounting for approximately one-third of all lymphoma cases worldwide. Notwithstanding that unprecedented scientific progress has been achieved over the years,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jiaqin, Yuan, Wei, Zhang, Junhui, Li, Ling, Zhang, Lei, Zhang, Xudong, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048048/
https://www.ncbi.nlm.nih.gov/pubmed/35498426
http://dx.doi.org/10.3389/fendo.2022.846357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048048/
https://www.ncbi.nlm.nih.gov/pubmed/35498426
http://dx.doi.org/10.3389/fendo.2022.846357

Ejemplares similares